Investing.com — Synopsys Inc (NASDAQ:).’s proposed $35 billion acquisition of software developer Ansys (NASDAQ:) Inc. has come under scrutiny by the UK’s Competition and Markets Authority (CMA). The watchdog has raised questions about potential competition issues in the supply of semiconductor chip design and light simulation products in the UK.

The CMA issued a statement indicating that the deal could face a more thorough antitrust investigation if the two companies fail to submit suitable proposals addressing the identified competition concerns. This announcement was given on Friday.

Synopsys, however, is already taking measures to address the issues raised by the CMA, according to a company spokesperson. The company remains optimistic about the progress of the deal, with the spokesperson stating, “We continue to expect the transaction to close in the first half of 2025.”

The acquisition, an all-American deal, is part of Synopsys’ strategic plan to expand its software development capabilities. The deal’s successful completion is contingent on meeting regulatory requirements, including addressing the concerns raised by the CMA.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.


Source link

Best Brokers

Unmatched trading fees, generous bonuses, top notch Regulation Frame.

T&Cs Apply

Risk disclosure: All investments involve a degree of risk of some kind. Trading financial derivative products comes with a high risk of losing money rapidly due to leverage.

Top-Tier Regulations. Unmatched Spreads and Commissions. Trading View is available.

T&Cs Apply

Financial Spread Trades and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 84.7% of retail investor accounts lose money when trading CFDs with this provider.

Modern and Intuitive Interfaces, Solid Regulatory Frame, and excellent Trading Fees.

T&Cs Apply
Risk warning: Trading derivatives is highly speculative, carries an inherent risk of loss and is not suitable for all investors. Before trading, you are strongly advised to read and ensure that you understand the relevant risk disclosures and warnings.

Highly Regulated. Low Spreads and Commissions. Vast Account Options.

T&Cs Apply

Risk Warning: Trading derivatives carries significant risks. It is not suitable for all investors and if you are a professional client, you could lose substantially more than your initial investment.